« Return to News | Awards & Advancement

Chiltern wins PharmaTimes award

Monday, February 4, 2013 10:23 AM

Chiltern International, a global CRO, has won an award at the PharmaTimes Annual Awards 2012. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Marc Joseph, resourcing manager, global resourcing solutions was awarded the “Clinical Recruiter of the Year Silver Award.” In addition, Lindyanne Alexander, team leader, global clinical development, was a finalist for the “Clinical Team Leader of the Year” category.

“I am delighted that our finalists represent not only Chiltern’s outstanding operational people but also our dedicated and professional recruitment team,” said Linda Christmas, chief resourcing officer, global resourcing solutions, Chiltern. “In global resourcing solutions, our commitment is to recruit and place the best talents for our clients. I am absolutely delighted to be able to work with such a great team each and every day.”

Jim Esinhart, Chiltern CEO, added, “I am extremely proud of every Chiltern colleague nominated for an award and this recognition is a testament to their outstanding abilities. Their achievements support Chiltern’s mission to deliver innovative, flexible and quality services to meet our clients’ clinical research needs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.